NeoProgen
Baltimore
About NeoProgen
NeoProgen is a therapeutics company that focuses on advancing neonatal cardiac progenitor cells. The company specializes in the fields of biotechnology and cardiac therapy. NeoProgen was founded in 2018 and headquartered in Maryland, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Oct 2019)
- Website: neoprogen.com
- Phone: 410-874-0055
Industries & Categories
Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/neoprogen-127262 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.